the Company's policy of establishing separate entities to
commercialize sufficiently developed technologies addressing
identifiable needs within particular communities, Endogenics, Inc. is
CDR's first wholly owned subsidiary.
purpose is to commercially exploit CDR's cell modeling technologies
in the bio-medical research and educational markets. For more
information about this exciting new venture, please visit